Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-5x
Shrank
—
—
Grew
—
1 Year
Score—
Net Growth-5x
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
—
-32.11%
60%
—
—
20%
—
5 Years
Score—
Net Growth-32.11%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Windtree Therapeutics Inc fundamental performance
Between 2014 and 2024, revenue declined from $ 2M to $ 0.00 and net income went from -$ 44M to -$ 5M. Revenue increased in 3 of those 10 years; net income in 5.
Between 2004 and 2024, revenue declined from $ 1M to $ 0.00 and net income went from -$ 46M to -$ 5M. Revenue increased in 7 of those 20 years; net income in 11.
Windtree Therapeutics Inc currently holds a 20-year HDB Score of 2.6 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.00 | — |
1 Year2025-08-13 | $ 0.54 | -99.96% |
5 Years2021-08-13 | $ 81.9K | -100.00% |
10 Years2016-08-12 | $ 1000K | -100.00% |
20 Years2006-08-11 | $ 1000K | -100.00% |
30 Years1996-08-13 | $ 1000K | -100.00% |
All Time1995-08-08 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | 20 Years2006-08-11 | 30 Years1996-08-13 | All Time1995-08-08 |
|---|---|---|---|---|---|---|---|
| Price | $ 0.00 | $ 0.54 | $ 81.9K | $ 1000K | $ 1000K | $ 1000K | $ 1000K |
| Return | — | -99.96% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 90K | -$ 40M | $ 204K |
| 2024 | $ 0.00 | -$ 5M | $ 1M |
| 2023 | $ 0.00 | -$ 20M | $ 4M |
| 2022 | $ 0.00 | -$ 39M | $ 6M |
| 2021 | $ 0.00 | -$ 67M | $ 22M |
| 2020 | $ 0.00 | -$ 30M | $ 16M |
| 2019 | $ 198K | -$ 27M | $ 22M |
| 2018 | $ 1M | -$ 20M | $ 25M |
| 2017 | $ 1M | -$ 18M | $ 1M |
| 2016 | $ 2M | -$ 39M | $ 5M |
| 2015 | $ 987K | -$ 55M | $ 38M |
| 2014 | $ 2M | -$ 44M | $ 44M |
| 2013 | $ 388K | -$ 45M | $ 86M |
| 2012 | $ 195K | -$ 37M | $ 26M |
| 2011 | $ 582K | -$ 20M | $ 10M |
| 2010 | -$ 19M | $ 10M | |
| 2009 | -$ 30M | $ 15M | |
| 2008 | $ 4M | -$ 39M | $ 24M |
| 2007 | -$ 40M | $ 53M | |
| 2006 | -$ 46M | $ 26M | |
| 2005 | $ 134K | -$ 58M | $ 50M |
| 2004 | $ 1M | -$ 46M | $ 32M |
| 2003 | $ 1M | -$ 24M | $ 29M |
| 2002 | $ 1M | -$ 17M | $ 19M |
| 2001 | $ 1M | -$ 11M | $ 16M |
| 2000 | $ 741K | -$ 10M | $ 18M |
| 1999 | $ 178K | -$ 4M | $ 3M |
| 1998 | $ 100K | -$ 15M | $ 1M |
| 1997 | $ 700K | -$ 9M | $ 6M |
| 1996 | $ 200K | -$ 2M | $ 200K |
| IPO1995 | $ 100K | -$ 2M |
Explore beyond WINT
You're looking at Windtree Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
